Abstracts from the 4th meeting are available
Papers from the 3rd meeting
3rd AAA. January 2008, Florida, USA.
Published papers (In a supplement of Medical Mycology 2009)
In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus. A. Alastruey-Izquierdo, I. Cuesta, J. Houbraken, M. Cuenca-Estrella, A. Monzón and J. L. Rodriguez-Tudela. Medical Mycology. 2009; AAA3 supplement:Paper
Interaction of Aspergillus with human respiratory mucosa: a study with organ culture model. R. Amitani and R. Kawanami. Medical Mycology. 2009; AAA3 supplement:Paper
Aspergillus terreus complex. S. A. Balajee. Medical Mycology. 2009; AAA3 supplement:Paper
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma. B. Bellete, H. Raberin, J. Morel, P. Flori, J. Hafid and R. T. M. Sung. Medical Mycology. 2009; AAA3 supplement:Paper
Aspergillus: a primer for the novice. J. W. Bennett. Medical Mycology. 2009; AAA3 supplement:Paper
Nail infection by Aspergillus ochraceopetaliformis. J. Brasch, J. Varga, J. M. Jensen, F. Egberts and K. Tintelnot. Medical Mycology. 2009; AAA3 supplement:Paper
Detection of 2-Pentylfuran in the breath of patients with Aspergillus fumigatus. S. T. Chambers, M. Syhre, D. R. Murdoch, F. McCartin and M. J. Epton. Medical Mycology. 2009; AAA3 supplement:Paper
Nutrient sensing G protein-coupled receptors: interesting targets for antifungals? P. V. Dijck. Medical Mycology. 2009; AAA3 supplement:Paper
Using aCGH to study intraspecific genetic variability in two pathogenic molds, Aspergillus fumigatus and Aspergillus flavus. N. D. Fedorova, S. Harris, D. Chen, D. W. Denning, J. Yu, P. J. Cotty and W. C. Nierman. Medical Mycology. 2009; AAA3 supplement:Paper
Imaging living cells of Aspergillus in vitro. P. C. Hickey and N. D. Read. Medical Mycology. 2009; AAA3 supplement:Paper
Invasion of the alveolar-capillary barrier by Aspergillus spp.: therapeutic and diagnostic implications for immunocompromised patients with invasive pulmonary aspergillosis. W. W. Hope. Medical Mycology. 2009; AAA3 supplement:Paper
Vaccine progress. J. I. Ito, J. M. Lyons, D. Diaz-Arevalo, T. B. Hong and M. Kalkum. Medical Mycology. 2009; AAA3 supplement:Paper
MLST versus microsatellites for typing Aspergillus fumigatus isolates. C. H. W. Klaassen. Medical Mycology. 2009; AAA3 supplement:Paper
Aspergillus PCR formidable challenges and progress. L. Klingspor and J. Loeffler. Medical Mycology. 2009; AAA3 supplement:Paper
Echinocandin activity against Aspergillus spp. and the importance of pharmacodynamics. J. S. Lewis. Medical Mycology. 2009; AAA3 supplement:Paper
Effect of competition on the production and activity of secondary metabolites in Aspergillus species. L. Losada, O. Ajayi, J. C. Frisvad, J. Yu and W. C. Nierman. Medical Mycology. 2009; AAA3 supplement:Paper
Clinical trial design for invasive aspergillosis: time to cast a different mold. M. Miceli and E. Anaissie. Medical Mycology. 2009; AAA3 supplement:Paper
Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosis. J. W. Mouton, D. T. A. Te Dorsthorst, J. F. G. M. Meis and P. E. Verweij. Medical Mycology. 2009; AAA3 supplement:Paper
Risk stratification for invasive aspergillosis: early assessment of host susceptibility. T. F. Patterson. Medical Mycology. 2009; AAA3 supplement:Paper
Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis - a review. M. Pihet, J. Carrere, B. Cimon, D. Chabasse, L. Delhaes, F. o. Symoens and J.-P. Bouchara. Medical Mycology. 2009; AAA3 supplement:Paper
What is a species in Aspergillus? R. A. Samson and J. Varga. Medical Mycology. 2009; AAA3 supplement:Paper
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus. W. V. D. Sande, M. Tavakol, W. V. Vianen and I. A. J. M. Bakker-Woudenberg. Medical Mycology. 2009; AAA3 supplement:Paper
Allergic fungal sinusitis: pathophysiology, diagnosis and management. M. S. Schubert. Medical Mycology. 2009; AAA3 supplement:Paper
Cerebral aspergillosis: tissue penetration is the key. S. Schwartz and E. Thiel. Medical Mycology. 2009; AAA3 supplement:Paper
Invasive aspergillosis in chronic granulomatous disease. B. H. Segal and L. R. Romani. Medical Mycology. 2009; AAA3 supplement:Paper
Recognizing therapeutic failure. K. A. Sepkowitz. Medical Mycology. 2009; AAA3 supplement:Paper
Evidence-based approach to challenging issues in the management of invasive aspergillosis. N. Singh. Medical Mycology. 2009; AAA3 supplement:Paper
Sick Building Syndrome: is mould the cause? A. I. Terr. Medical Mycology. 2009; AAA3 supplement:Paper
Essential pathway identification: from in silico analysis to potential antifungal targets in Aspergillus fumigatus. J. Thykaer, M. R. Andersen and S. E. Baker. Medical Mycology. 2009; AAA3 supplement:Paper
Functionalized nanocarrier(s) to image and target fungi infected immune cells. S. P. Vyas, K. Khatri and A. K. Goyal. Medical Mycology. 2009; AAA3 supplement:Paper
Diagnostic imaging of experimental invasive pulmonary aspergillosis. T. J. Walsh, V. Petraitis, R. Petraitiene, J. Solomon, J. D. Bacher, L. Greene, M. Cotton, A. Groll, E. Roilides, N. Avila, V. Pyrgos and S. Shoham. Medical Mycology. 2009; AAA3 supplement:Paper
Preventing healthcare-associated Aspergillus infections: review of recent CDC/HICPAC recommendations. D. J. Weber, A. Peppercorn, M. B. Miller, E. Sickbert-Benett and W. A. Rutala. Medical Mycology. 2009; AAA3 supplement:Paper
Paradoxical echinocandin activity: a limited in vitro phenomenon? N. P. Wiederhold. Medical Mycology. 2009; AAA3 supplement:Paper
Aspergillus fumigatus metabolism: Clues to mechanisms of in vivo fungal growth and virulence. S. D. Willger, N. Grahl and R. A. Cramer. Medical Mycology. 2009; AAA3 supplement:Paper
Alarmins and antimicrobial immunity. D. Yang and J. J. Oppenheim. Medical Mycology. 2009; AAA3 supplement:Paper